ScholarIQanswers from OpenAlex
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
PaperCitations, authors & open-access status
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer have?
ScholarIQcitation count
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer has 6,267 citations in the OpenAlex counts ScholarIQ stores.
When was Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer published?
ScholarIQyear
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer has 2015 year in the ScholarIQ index.
What is the open-access status of Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer?
ScholarIQoa status
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer?
ScholarIQdoi
The DOI for Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer is on the source record.
What is the PMID of Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer?
ScholarIQpmid
The PMID for Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer is on the source record.
What is the OpenAlex record for Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer?
ScholarIQopenalex
The OpenAlex for Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer is on the source record.